Demo Sign up Log In

Ligand Pharmaceuticals Inc (LGND)

Income Tax Expense

$15.80M

Quarterly · Period ending: Jun 30, 2026 · USD

LGND Income Tax Expense

Latest reported$15.80Mperiod endingJun 30, 2026

Latest reported$15.80Mperiod endingJun 30, 2026

LGND Quarterly Income Tax ($0.00 → $15.80M)

Quarterly income tax expense

High-resolution chart · PNG

LGND income tax expense history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ligand Pharmaceuticals Inc Income Tax Expense — Quarterly (USD)
Period ending	Income Tax Expense (USD)
Jun 30, 2001	2,950,000
Mar 31, 2001	3,215,000
Dec 31, 2000	16,389,000
Sep 30, 2000	2,969,000
Jun 30, 2000	2,882,000
Mar 31, 2000	4,254,000
Dec 31, 1999	11,100,000
Sep 30, 1999	3,200,000
Jun 30, 1999	2,200,000
Mar 31, 1999	1,900,000
Dec 31, 1998	16,800,000
Sep 30, 1998	29,400,000
Jun 30, 1998	1,200,000
Mar 31, 1998	900,000
Dec 31, 1997	66,200,000
Sep 30, 1997	1,300,000
Jun 30, 1997	1,000,000
Mar 31, 1997	1,000,000
Dec 31, 1996	1,200,000
Sep 30, 1996	1,400,000
Jun 30, 1996	1,100,000
Mar 31, 1996	1,000,000
Dec 31, 1995	1,000,000
Sep 30, 1995	800,000
Jun 30, 1995	41,500,000
Mar 31, 1995	1,700,000
Dec 31, 1994	1,700,000
Sep 30, 1994	1,500,000
Jun 30, 1994	1,700,000
Mar 31, 1994	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.